AbbVie's corporate venture arm, which invests in early-stage biotech companies in AbbVie's therapeutic areas including cancer. Its web pages blocked automated access at the time of research.
AbbVie Ventures is the corporate venture capital group of AbbVie, the North Chicago-based pharmaceutical company, and invests strategically in early-stage companies developing new therapeutics and platforms in AbbVie's areas of interest, which include oncology, immunology and neuroscience. Both the AbbVie Ventures overview and portfolio pages on abbvie.com returned HTTP 403 (Cloudflare) on every attempt with two different fetch methods, so the firm's own description, founding year, strategy and named oncology portfolio companies could not be confirmed from a primary source.
No OnCo company names this investor yet. Portfolio links are declared on the startup record (`investors`), so adding one there lists it here.